Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
2104.58%
↑ 3571% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
57.32%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 2104.58% |
| Q3 2025 | -101.15% |
| Q2 2025 | 165.62% |
| Q1 2025 | -28.11% |
| Q4 2024 | 8.85% |
| Q3 2024 | -6.05% |
| Q2 2024 | 1.72% |
| Q1 2024 | 3.08% |
| Q4 2023 | -1.40% |
| Q3 2023 | 0.21% |
| Q2 2023 | -10.05% |
| Q1 2023 | -2.39% |
| Q4 2022 | -21.33% |
| Q3 2022 | -289.12% |
| Q2 2022 | 171.10% |
| Q1 2022 | -470.08% |
| Q4 2021 | 128.14% |
| Q3 2021 | -27.97% |
| Q2 2021 | -34.33% |
| Q1 2021 | -11.17% |
| Q4 2020 | -228.67% |
| Q3 2020 | 196.09% |
| Q2 2020 | -1.59% |
| Q1 2020 | -36.51% |
| Q4 2019 | 7.42% |
| Q3 2019 | 16.03% |
| Q2 2019 | -11.93% |
| Q1 2019 | -8.50% |
| Q4 2018 | -29.30% |
| Q3 2018 | 30.04% |
| Q2 2018 | 8.89% |
| Q1 2018 | 35.79% |
| Q4 2017 | -39.97% |
| Q3 2017 | -12.00% |
| Q2 2017 | -10.70% |
| Q1 2017 | -253.48% |
| Q4 2016 | -76.05% |
| Q3 2016 | 1150.29% |
| Q2 2016 | 23.31% |
| Q1 2016 | -46.42% |